Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract — a Report of two Cases of a new Provisional Entity on the World Health Organization Classification of Hematolymphoid Tumors
Restricted accessCase reportFirst published online 2022
Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract — a Report of two Cases of a new Provisional Entity on the World Health Organization Classification of Hematolymphoid Tumors
Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract is a new provisional entity listed in the structure of the forthcoming fifth edition of the World Health Organization (WHO) Classification of Hematolymphoid Tumors. It was first named as “NK-cell enteropathy” and “Lymphomatoid gastropathy” by two independent series a decade ago. Molecular or cytogenetic studies have lent support to the clonal/neoplastic nature of this entity. Herein we add two of such cases that still challenge pathologists and were previously diagnosed as aggressive lymphomas of NK/T derivation.
SoderquistCRBhagatG. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders. Semin Diagn Pathol. 2019;37(1):11-23. doi:10.1053/j.semdp.2019.08.001.
2.
VlietCvSpagnoloDV. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update. Pathology. 2019;52(1):128-141. doi:10.1016/j.pathol.2019.10.001.
3.
MansoorAPittalugaSBeckPLWilsonWHFerryJAJaffeES. NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood. 2011;117(5):1447-1452. doi:10.1182/blood-2010-08-302737.
4.
TakeuchiKYokoyamaMIshizawaS, et al.Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood. 2010;116(25):5631-5637. doi:10.1182/blood-2010-06-290650.
5.
TakataKNoujima-HaradaMMiyata-TakataT, et al.Clinicopathologic analysis of 6 lymphomatoid gastropathy cases. Am J Surg Pathology. 2015;39(9):1259-1266. doi:10.1097/pas.0000000000000443.
6.
IshibashiYMatsuzonoEYokoyamaF, et al.A case of lymphomatoid gastropathy: a self-limited pseudomalignant natural killer (NK)-cell proliferative disease mimicking NK/T-cell lymphomas. Clin J Gastroenterology. 2013;6(4):287-290. doi:10.1007/s12328-013-0397-7.
7.
YamamotoJFujishimaFIchinohasamaRImataniAAsanoNHarigaeH. A case of benign natural killer cell proliferative disorder of the stomach (gastric manifestation of natural killer cell lymphomatoid gastroenteropathy) mimicking extranodal natural killer/T-cell lymphoma. Leukemia Lymphoma. 2011;52(9):1803-1805. doi:10.3109/10428194.2011.573030.
8.
IsomJAArroyoMRReddyD, et al.NK Cell enteropathy: a case report with 10 years of indolent clinical behaviour. Histopathology. 2018;73(2):345-350. doi:10.1111/his.13502.
9.
Swerdlow SH, Campo E, Harris NL, eds., et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Vol 2. International Agency for Research on Cancer; 2016.
10.
Board WC of TE. Digestive System Tumours. Vol 3. 5th ed. International Agency for Research on Cancer; 2020.
KimSJJungHAChuangSS, et al.Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia lymphoma study group. J Hematol Oncol. 2013;6(1):86. doi:10.1186/1756-8722-6-86.
13.
XiaoWGuptaGKYaoJ, et al.Recurrent somatic JAK3 mutations in NK-cell enteropathy. Blood. 2019;134(12):986-991. doi:10.1182/blood.2019001443.
